Latest Ensysce Biosciences News & Updates

See the latest news and media coverage for Ensysce. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Ensysce Biosciences (Ensysce)

Biotechnology company developing abuse-deterrent pain therapies

ensysce.com
Headquarters
La Jolla, United States
Founded year
2008
Company type
Public company
Number of employees
10–50
Industry
Pharmaceuticals

Last updated

Latest news about Ensysce Biosciences (Ensysce)

In short: Ensysce completed its PF614-MPAR-102 clinical study and finalized a $15 million NIDA grant for its overdose-protection technology.

Company announcements

Ensysce

Ensysce receives FDA Breakthrough Therapy designation for PF614-MPAR

The FDA recognized it as a substantial improvement over existing therapies for oral overdose protection. Ensysce has enrolled the first patient in Part 3 of the PF614-MPAR-102 study.

Unlock all announcements with a

Media coverage

Yahoo Finance

Ensysce Biosciences Stock Doubles In One Trading Session - Here s Why

Ensysce Biosciences, Inc (NASDAQ:ENSC) stock gained almost 100% with a strong session volume...

Unlock all articles with a

Never miss news about Ensysce

Track Ensysce and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.